Boxer Michael A's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed Mar 11, 2025
- Accession no.
- 0001127602-25-009034
- Filed
- Mar 11, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.01M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boxer Michael ACIK 0001726596 | Officer (SVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | SSaleDisposed | −3,775.48 | $532.53 | −$2,010,556.36 | 10,815.95 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.